Detection of Early Idiopathic Pulmonary Fibrosis

The Role of the miR200 Family in the Restoration of Normal Lung Homeostasis and Detection of Early IPF

The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.

Inclusion Criteria for IPF Patients:

• Informed consent
• Subjects ≥ 40 y.o.
• Naive patients with no IPF treatment
• IPF diagnosis based on the ATS/ERS/JRS/ALAT criteria

Inclusion Criteria for non-IPF ILD Patients:

• Informed consent
• Subjects ≥ 18 y.o.
• ILD diagnosis

Exclusion Criteria:

• HIV
• Hepatitis B
• Hepatitis C
• Pregnant or lactating women

inclusion criteria for controls: informed consent >18 years old; no lung diseases